Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

PParabilis Medicines, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
P

Parabilis Medicines, Inc.

  • Overview
  • Financial statements
  • Metrics
    • Revenue & profit
    • Revenue by segment
    • Launches
    • Revenue concentration
    • Margins
    • Contracted revenue
    • Off-balance-sheet commitments
    • Cash flow
    • Cash & debt
    • Earnings per share
    • P/E ratio
    • Share count & dilution
  • Quarterly earnings
  • Similar companies
  • Insider Transactions
Loading financial graphs

Metrics

Revenue & profit
Revenue by segment
Margins
Contracted revenue
Cash flow
Cash & debt
Earnings per share
Share count & dilution

Metrics

Compare sales with the profit left after direct costs and the profit left after all expenses and taxes.Formula: Gross profit = revenue − cost of revenue Net income = total income − total expenses
Q2 ’2620252026-50M-40M-30M-20M-10M0Latest period Q2 '26. Revenue 148K. Gross profit 148K. Net profit -52.46M.
RevenueGross profitNet profit
See how much of each dollar of sales remains after direct costs, after running the business, and after all expenses and taxes.Formula: Gross margin = gross profit ÷ revenue × 100% Operating margin = operating income ÷ revenue × 100% Net margin = net income ÷ revenue × 100%
Q2 ’2620252026-30,000%-20,000%-10,000%0%Latest period Q2 '26. Gross margin 100%. Operating margin -34,382.4%. Net profit margin -35,448%.
Gross marginOperating marginNet profit marginNo revenue (margins undefined)
Compare the company’s cash cushion with its borrowings. Negative net cash means debt is greater than cash.Formula: Net cash = cash − debt
2026202520260200M400M600M800M1B
      Latest period 2026. Cash 1.1B. Debt 6.4M.
      CashDebtNet cash
      Profit for each share over the trailing 12 months, adjusted for stock splits.Formula: Earnings available to common shareholders ÷ weighted-average shares
      Using split history cached 2026-09-23; assuming no new splits
      four_consecutive_quarters_unavailableMissingfour_consecutive_quarters_unavailableMissingQ2 ’2620252026-1-0.500.51
      • 2025-06-30: four consecutive quarters unavailable
      • Q2 2026: four consecutive quarters unavailable
      • Earnings period 2025-04-01 to 2025-06-30. Shares as of 2025-06-30: unavailable source shares.
      • Earnings period 2026-04-01 to 2026-06-30. Shares as of 2026-06-30: unavailable source shares.
      Latest period Q2 2026. .
      EPS (TTM)
      How much investors pay for each dollar of the company’s yearly earnings. It is not useful when the company has no profit.Formula: Share price ÷ trailing 12-month EPS
      Using split history cached 2026-09-23; assuming no new splits
      Security type not verifiedMissingSecurity type not verifiedMissingQ2 ’26202520260x0.2x0.4x0.6x0.8x1x
      • 2025-06-30: Security type not verified
      • Q2 2026: Security type not verified
      • Earnings period 2025-04-01 to 2025-06-30. Shares as of 2025-06-30: unavailable source shares.
      • Earnings period 2026-04-01 to 2026-06-30. Shares as of 2026-06-30: unavailable source shares.
      Latest period Q2 2026. P/E ratio Missing.
      P/E ratio
      See how the number of shares changes over time. More shares can mean each existing share owns a smaller slice of the company.Formula: Outstanding shares = issued shares − treasury shares Share-count growth = (current shares ÷ previous shares − 1) × 100%
      Stock split history may be out of date.
      202620252026020M40M60M80M100M120M
          Latest period 2026. Shares outstanding 121.9M. Class detail unavailable 121.9M.
          Class detail unavailable